Sunfish, a family building platform, has launched a new AI-powered egg freezing success program – combining personalized outcome predictions with a financial guarantee: if a patient doesn’t reach their target number of frozen eggs within the guaranteed budget, Sunfish covers the cost of an additional cycle.
The program uses Sunfish’s proprietary AI platform to analyze individual biodata and clinical outcomes, generating a personalized plan that includes a target egg count and transparent cost projections before treatment begins. It also includes one year of storage, lowest price match on medication, flexible payment options, and a human care team for support throughout.
“As someone who has navigated the complicated IVF process and as I continue on my own path to parenthood, I’ve seen firsthand how the healthcare system often leaves patients to manage the financial, emotional, and physical stress alone,” said co-founder and CEO Angela Rastegar. “Fertility preservation today requires women to be an unpaid project manager for their own family planning, but now, Sunfish makes the process more seamless and supportive so women don’t have to go at it alone like I did.”
The financial context is stark: According to Sunfish, fertility treatments have become the fourth largest type of household debt in the U.S., behind only home ownership, student debt, and car payments. And the administrative burden is significant – patients navigate an average of more than 28 touchpoints and four to twelve hours just to begin the process.
Sunfish reports its patients currently see a 70.8% success rate (achieving pregnancy and graduation to an OB-GYN), compared to a national average of 54.3%. The company partners with more than 50 fertility providers including IVF clinics, egg banks, fertility pharmacies, sperm banks, and surrogacy agencies. The egg freezing program follows its existing IVF success program.
More than 40,000 women froze their eggs in 2023 alone, and the global fertility market is projected to triple in the next decade. The program offers 100% eligibility regardless of age, diagnosis, or insurance status.
